因此，不会出现全身酸中毒或其他与口服碳酸酐酶抑制剂有关的副作用。
Thus, systemic acidosis or the other side effects associated with oral carbonic anhydrase inhibitors are not expected to occur.
乙酰唑胺、醋甲唑胺、双氯非那胺等碳酸酐酶抑制剂自1954年起就被应用于青光眼的降眼压治疗。
Carbonic anhydrase inhibitors (CAIs) were first used to lower intraocular pressure (IOP) in glaucoma in 1954, with the introduction of acetazolamide, methazolamide and diclofenamide were subsequently.
应用推荐